Obstetrical and perinatal consequences of childbirth in women with antenatally undiagnosed fetal growth restriction
DOI:
https://doi.org/10.34287/MMT.4(59).2023.3Abstract
Fetal growth restriction (FGR) is one of the most studied topics in the medicine of the mother and fetus. However, not identified antenatally FGR can have an increased risk of both perinatal morbidity and mortality, as well as adverse long-term consequences. The identification of FGR during pregnancy will contribute to the reduction of both perinatal morbidity and perinatal mortality.
Aim. Based on a retrospective analysis, assess the obstetric and perinatal consequences of childbirth in women with antenatally undiagnosed fetal growth restriction.
Materials and methods. An analysis of 488 cases of childbirth in women with singleton pregnancy, who gave birth to a live child, was conducted. In all cases, the gestational age was ≥22 weeks with a fetal weight less than the 10th percentile for the corresponding gestational age. Depending on the antenatally established diagnosis of FGR, two study groups were formed: group I consisted of 204 (41.8 %) cases with antenatally diagnosed FGR, group II – 284 (58.2 %) cases in which signs of FGR were identified after the birth of the child. Maternal characteristics, neonatal outcomes, and evaluation of short-term infant outcomes were analyzed.
Results. Both groups were dominated by women with first births, the number of which was almost the same. Somatic pathology was almost 2 times more common in women of group I, 17.2 %, compared to 9.2 % of women in group II (p < 0.01), this indicates that the majority of women who were not diagnosed with FGR during pregnancy belong to the low-risk group. Fetuses with impaired blood flow in the umbilical cord arteries were twice as common in group I, 49.5 % versus 23.9 % in group II (p < 0.0001), and the frequency of absent/reversible end flow in the umbilical arteries in group I compared to group II, prevailed 3 times (p < 0.0001), indicating more serious lesions of the placenta and, as a result, early manifestation of the fetal condition disorder. The frequency of premature abdominal delivery was 3.75 times higher in group I compared to group II. The most frequent indication for cesarean delivery in both groups was signs of fetal distress syndrome. Analysis of neonatal outcomes showed that the average birth weight was significantly lower in group I and was 2180 ± 55 g against 2420 ± 61 g in group II (p < 0.0001). The need for hospitalization of newborns in the intensive care unit had no statistical difference between the groups (p > 0.05). However, the complications of the early neonatal period and the total length of stay in the hospital were greater in children of the I group, compared to the II group (p < 0.0001).
Conclusions. The results of the conducted research indicate a low level of prenatal diagnosis of fetal growth restriction. Most pregnant women with antenatally undiagnosed fetal growth restriction belong to the group of low perinatal risk. The most frequent indication for cesarean section operation, regardless of the date of delivery, in both groups were signs of fetal distress, the frequency of which was 1.5 times higher in the antenatally diagnosed fetal growth retardation group. Newborns with an undetected growth anomaly before delivery have an increased risk of fetal distress, the severity of which is determined by the degree of deterioration of fetal oxygenation, and not by weight percentile, which requires more careful observation of fetuses with signs of growth restriction.
References
Lees C, Stampalija T, Hecher K. Diagnosis and management of fetal growth restriction: the ISUOG guideline and comparison with the SMFM guideline. Ultrasound Obstet Gynecol. 2021;57(6):884-887. doi: 10.1002/uog.23664
Hromova AM, Berezhna VA. [Obstetric and antenatal risk factors for intrauterine growth restriction]. Zaporozhye Medical Journal. 2020;22(3):395401. Ukrainian. doi: 10.14739/2310-1210.2020.3.204949
Lees CC, Romero R, Stampalija T, Dall’Asta A, DeVore GA, Prefumo F, et al. Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach. Am J Obstet Gynecol. 2022;226(3):366-78. doi: 10.1016/j.ajog.2021.11.1357
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F. at al. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021;152 Suppl 1 (Suppl 1):3-57. doi: 10.1002/ijgo.13522
Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2-B17. doi: 10.1016/j.ajog.2020.05.010
Fetal Growth Restriction: ACOG Practice Bulletin, Number 227. Obstetrics and gynecology.2021;137(2):e16-e28. doi: 10.1097/ AOG.0000000000004251
Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for Gestational Age: Definitions and Epidemiology. Obstet Gynecol Clin North Am. 2021;48(2):267-79. doi: 10.1016/j.ogc.2021.02.002
Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G, Polglase GR, Miller SL. Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact. Front Endocrinol (Lausanne). 2019;10:55. doi: 10.3389/ fendo.2019.00055
Cetin I, Taricco E, Mandò C, Radaelli T, Boito S, Nuzzo AM, Giussani DA. Fetal Oxygen and Glucose Consumption in Human Pregnancy Complicated by Fetal Growth Restriction. Hypertension. 2020;75(3):748-54. doi: 10.1161/ HYPERTENSIONAHA.119.13727
Ratnasiri AWG, Parry SS, Arief VN, DeLacy IH, Halliday LA, DiLibero RJ, et al. Recent trends, risk factors, and disparities in low birth weight in California, 2005-2014: a retrospective study. Matern Health Neonatol Perinatol. 2018;4:15. doi: 10.1186/s40748-018-0084-2
Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of Intrauterine Growth Restriction and Small for Gestational Age Status With Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020;174(8):772-81. doi: 10.1001/jamapediatrics.2020.1097
Henrichs J, de Jonge A, Westerneng M, Verfaille V, Franx A, van der Horst HE, et al. Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study). Int J Environ Res Public Health. 2022;19(6):3312. doi: 10.3390/ijerph19063312
Pels A, Beune IM, van Wassenaer-Leemhuis AG, Limpens J, Ganzevoort W. Early-onset fetal growth restriction: A systematic review on mortality and morbidity. Acta Obstet Gynecol Scand. 2020;99(2):153-66. doi: 10.1111/ aogs.13702
Nohuz E, Rivière O, Coste K, Vendittelli F. Prenatal identification of small-for-gestational age and risk of neonatal morbidity and stillbirth. Ultrasound Obstet Gynecol. 2020;55(5):621-628. doi: 10.1002/uog.20282
Ego A, Monier I, Skaare K, Zeitlin J. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study. Ultrasound Obstet Gynecol. 2020;55(5):613-620. doi: 10.1002/uog.20414
Lubrano C, Taricco E, Coco C, Di Domenico F, Mandò C, Cetin I. Perinatal and Neonatal Outcomes in Fetal Growth Restriction and Small for Gestational Age. J. Clin. Med. 2022;11(10):2729. doi: 10.3390/jcm11102729
Kolokot NG. [Improvement of fetus growth restriction diagnostics in pregnant women by means of biochemical markers that characterize the disorder of stress-adaptation]. Zaporozhye Medical Journal. 2018;20(2):231-5. Ukrainian. doi: 10.14739/2310-1210.2018.02.125275
[On approval of the standard of medical care “Fetal growth retardation”. Order of the Ministry of Health of Ukraine No. 1718 on 2023 Oct 2] [Internet]. 2023 [cited 2023 Nov 21]. Ukrainian. Available from: https://moz.gov. ua/article/ministry-mandates/nakaz-moz-ukraini-vid-02102023--1718-pr o-zatverdzhennja-standartu-medichnoi-dopomogi-zatrimka-rostu-ploda
Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(2):298-312. doi: 10.1002/uog.22134
Pritchard N, Lindquist A, Siqueira IDA, Walker SP, Permezel M. INTERGROWTH-21st compared with GROW customized centiles in the detection of adverse perinatal outcomes at term. J Matern Fetal Neonatal Med. 2020;33(6):961-966. doi: 10.1080/14767058.2018.1511696
Beune IM, Bloomfield FH, Ganzevoort W, Embleton ND, Rozance PJ, van Wassenaer-Leemhuis AG, et al. Consensus Based Definition of Growth Restriction in the Newborn. J Pediatr. 2018;196:71-76.e1. doi: 10.1016/j. jpeds.2017.12.059
Simon LV, Hashmi MF, Bragg BN. APGAR Score. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023
Farsetti D, Pometti F, Tiralongo GM, Lo Presti D, Pisani I, Gagliardi G, et al. (2022). Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics. J Matern Fetal Neonatal Med. 2022;35(25):6593-6599. doi: 10.1080/14767058.2021.1918091